More on Fresenius WW---20,000 FATALITIES (NOT OMONTYS !!!)
An anaesthetic drip blamed for about 20,000 deaths worldwide is still used in Australia.
Other countries banned the drip in June and leading intensive-care specialists have condemned its continued use in Australia.
Experts at the Royal Prince Alfred Hospital, Royal North Shore Hospital and Melbourne's Austin Hospital say the starch-based drip increases risk of kidney disease and death.
Australia led scientific research into the risks of hydroxyethyl starch (HES), marketed locally as Voluven, but has been slow to withdraw it, unlike the US, Europe, Britain, Canada and Italy, the experts say.
In June, the US Food and Drug Administration issued a high-status warning that said recent data indicated an increased risk of mortality and renal injury and concluded that HES solutions should not be used in critically ill adult patients, including those in intensive-care units.
Britain's regulatory authority issued an urgent recall in June.
The drip is distributed by Fresenius Kabi Australia, which is part of a global concern.
A Scandinavian study comparing HES with other saline drips found that for every 13 patients treated in the trial, one died as a result of receiving HES fluids.
Rinaldo Bellomo, the director of intensive care research at the Austin Hospital, has criticised the government's Therapeutic Goods Administration for issuing ''a variety of platitudes''.